Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
about
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistanceUnusual susceptibility of a multidrug-resistant yeast strain to peptidic antifungals.P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.A combination of curcumin with either gramicidin or ouabain selectively kills cells that express the multidrug resistance-linked ABCG2 transporterChloroquine resistance in the malarial parasite, Plasmodium falciparum.In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity.Defective acidification in human breast tumor cells and implications for chemotherapy.Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells.Lysosomotropic agents increase vinblastine efflux from mouse MDR proximal kidney cells exhibiting vectorial drug transport.Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance.Designing multidrug-resistance modulators circumventing the reverse pH gradient in tumours.MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potential.Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells.Intracellular pH and multidrug resistance regulate complement-mediated cytotoxicity of nucleated human cells.
P2860
Q29615118-95412ACC-A7E3-4E6E-A033-F9F937492BBEQ33981198-54BAE508-2AC9-4C88-ADAD-82951F0DB6ECQ34142289-496DC734-8793-47F2-A720-7DA56C817113Q34467622-337CA100-784D-4F21-BDD0-9E69F2635357Q34811649-89B6EF63-93C6-47F2-9432-0FC11ABFF4D2Q36326998-2F8D995E-1477-4987-BB92-CE355ADD20FBQ36400861-D88E008C-79F6-429F-B15B-D812325A51FAQ40871608-246DCC83-89F9-4876-B365-B7280D05528BQ40970475-C0D18B91-C5BD-4FBB-9D60-05948F128986Q41764938-F0D18D42-9A70-4AB6-AF41-353A0293233AQ41943366-182CBBF0-D619-4544-BBC1-814E537C59A9Q43692525-428B6C76-A6A4-401C-9803-383B7061ACEDQ43764675-CB34BDC8-08A7-4C26-AEE4-DA4CB650F73EQ44381847-24F7B7EA-2257-4666-A716-764443FE048EQ54100223-B66C215A-C7D2-4548-B784-5EBB19C8A60B
P2860
Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Are altered pHi and membrane p ...... mediated multidrug resistance?
@ast
Are altered pHi and membrane p ...... mediated multidrug resistance?
@en
type
label
Are altered pHi and membrane p ...... mediated multidrug resistance?
@ast
Are altered pHi and membrane p ...... mediated multidrug resistance?
@en
prefLabel
Are altered pHi and membrane p ...... mediated multidrug resistance?
@ast
Are altered pHi and membrane p ...... mediated multidrug resistance?
@en
P2093
P2860
P356
P1476
Are altered pHi and membrane p ...... mediated multidrug resistance?
@en
P2093
P2860
P304
P356
10.1085/JGP.108.4.295
P577
1996-10-01T00:00:00Z